How Shingles Damages the Heart—and How to Stop It

More Than a Painful Rash

Most people know shingles as an agonizing, blistering rash that strikes one side of the body. Fewer realize that the virus behind it can silently damage the cardiovascular system, raising the risk of heart attack and stroke for years after the rash fades. With roughly one in three Americans expected to develop shingles in their lifetime, according to the Centers for Disease Control and Prevention, the stakes extend far beyond skin-deep pain.

A Virus That Never Leaves

Shingles is caused by the varicella-zoster virus (VZV), the same pathogen responsible for chickenpox. After a childhood bout of chickenpox resolves, the virus doesn't disappear. Instead, it retreats into clusters of nerve cells called dorsal root ganglia, where it lies dormant—sometimes for decades.

When the immune system weakens due to aging, stress, illness, or immunosuppressive medication, VZV can reactivate. It travels along sensory nerves back to the skin, producing the characteristic painful rash. The risk rises sharply after age 50, and by age 85, about half of all adults will have experienced at least one episode.

How the Virus Attacks Blood Vessels

What makes VZV unusual—and dangerous—is its ability to invade arteries. According to research published in the Journal of the American Heart Association, VZV is the only known human virus demonstrated to replicate directly inside arterial walls. Once there, it triggers a cascade of vascular inflammation.

The virus spreads from nerve fibers into nearby blood vessels, where it can cause a condition known as VZV vasculopathy—thickening, scarring, and remodeling of vessel walls. This process narrows arteries and promotes clot formation, which can lead to heart attack or stroke. VZV vasculopathy can affect both large and small blood vessels in the brain and heart.

A landmark study by the National Heart, Lung, and Blood Institute found that people who had shingles faced a 30% higher risk of a major cardiovascular event, a 38% higher risk of stroke, and a 25% higher risk of coronary heart disease. The elevated risk persisted for up to 12 years after the initial shingles episode.

The Immune Feedback Loop

The relationship between shingles and heart disease runs in both directions. Research from Stanford University showed that people with coronary artery disease already carry immune cells that are less effective at keeping VZV in check, making them more susceptible to reactivation. In other words, heart disease makes shingles more likely, and shingles makes heart disease worse—a dangerous feedback loop.

Vaccination as a Shield

The good news is that vaccination appears to break this cycle. A study presented at the American College of Cardiology analyzed over 246,000 U.S. adults with atherosclerotic heart disease and found that those who received the shingles vaccine were 32% less likely to suffer a heart attack, 25% less likely to have a stroke, and 25% less likely to develop heart failure. Among the highest-risk patients, the vaccine cut major cardiac events by 46% and deaths by 66% within one year.

Separate research from the European Society of Cardiology confirmed that the protective cardiovascular benefit of the shingles vaccine lasts up to eight years.

Who Should Get Vaccinated

The CDC recommends the recombinant shingles vaccine (Shingrix) for adults aged 50 and older, as well as for immunocompromised adults aged 19 and older. The vaccine is more than 90% effective at preventing shingles and is given in two doses, two to six months apart.

Given the growing evidence that shingles poses a serious and long-lasting threat to the heart, experts increasingly view vaccination not just as protection against a painful rash—but as a cardiovascular intervention in its own right.